Is UNII-33E86K87QN Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-33E86K87QN? Is UNII-33E86K87QN safe for nursing mother and child? Does UNII-33E86K87QN extracts into breast milk? Does UNII-33E86K87QN has any long term or short term side effects on infants? Can UNII-33E86K87QN influence milk supply or can UNII-33E86K87QN decrease milk supply in lactating mothers?
Answer by DrLact: About UNII-33E86K87QN usage in lactation
No information is available on the clinical use of UNII-33E86K87QN during breastfeeding. Because UNII-33E86K87QN is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is 3.9 to 4.8 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-33E86K87QN therapy and for 4 months after the last dose.
Alternate Drugs
Vincristine(Dangerous)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Imatinib(Unsafe)
Cladribine(Dangerous)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Alemtuzumab(Low Risk)
Exemestane(Dangerous)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Allopurinol(Safe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)